HIGHLIGHTS
- who: . and colleagues from the Chengdu Institute of Biology (CAS), China Guangzhou University of Chinese have published the article: Pharmacological effects of Chinese medicine modulating ammasomes in fatty liver treatment, in the Journal: (JOURNAL)
- how: A clinical study showed that NLRP3 inflammasome activation exhibits a protective effect on the development of HCC but other experimental data indicated that NLRP3 deficiency in HCC cells enhance surveillance of NK cells to delay the tumor development in the xenograft mice model (Wei et_al 2014 Lee et_al 2021).
- future: Collectively even though further studies are required to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.